Experts: cancer drugs should be licensed on smaller trials Media release 14 February 2015 Pages: 1 - 1
Pfizer lowers price of Prevenar 13 in world's poorest countries News item 14 February 2015 Pages: 3 - 3
AHF hospital expenditures in the US: cost drivers examined Clinical study 14 February 2015 Pages: 4 - 4
Assessing cost efficacy of FDA-approved psoriasis treatments Clinical study 14 February 2015 Pages: 5 - 5
Factors affecting GP charges and bulk-billing in Australia Clinical study 14 February 2015 Pages: 11 - 11
High cost of plerixafor for HPC mobilization in AL amyloidosis Clinical study 14 February 2015 Pages: 12 - 12
How patients reduce their prescription drug costs in the US Epidemiology population study 14 February 2015 Pages: 13 - 13
Joint EU report analyses antimicrobial use and resistance Media release 14 February 2015 Pages: 14 - 14
Office-based fulguration more cost effective than TURB Clinical study 14 February 2015 Pages: 16 - 16
Proton vs photon radiation with respect to GHD risk in children Clinical study 14 February 2015 Pages: 17 - 17
Real-world usage and cost of exenatide and liraglutide Clinical study 14 February 2015 Pages: 18 - 18
Reimbursement of targeted cancer therapy varies considerably Clinical study 14 February 2015 Pages: 20 - 20
Reminder letters increase uptake of childhood vaccines in Denmark Media release 14 February 2015 Pages: 21 - 21
Small, but noteworthy dis-utility of pill taking for CVD prevention Clinical study 14 February 2015 Pages: 22 - 22
Substantial variation in costs after PCI in the US VA system Clinical study 14 February 2015 Pages: 23 - 23
Treating hypertension based on 2014 guidelines cost saving Clinical study 14 February 2015 Pages: 24 - 24
US had substantial increases in prescription drug prices in 2014 Media release 14 February 2015 Pages: 26 - 26
Increase in funding to combat rise in drug overdose problem in US News item 14 February 2015 Pages: 30 - 30